A double-blind study comparing ibuprofen 1800 mg or 2400 mg daily and placebo in sports injuries

J Int Med Res. 1986;14(3):142-7. doi: 10.1177/030006058601400305.

Abstract

In a double-blind, placebo-controlled study of forty-six patients with acute ligamentous damage of the knee, ibuprofen in dosages 1800 mg and 2400 mg produced significant improvements in joint mobility, weight bearing ability and match fitness. Joint effusion, pain on stress and pain severity was significantly improved by all three treatments. Only two patients reported side-effects (one while taking placebo and one taking ibuprofen 2400 mg). The study confirmed the efficacy and excellent tolerance to ibuprofen in patients with sports injuries to the knee.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Athletic Injuries / drug therapy*
  • Athletic Injuries / physiopathology
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Ibuprofen / administration & dosage
  • Ibuprofen / adverse effects
  • Ibuprofen / therapeutic use*
  • Knee Injuries / drug therapy*
  • Knee Injuries / physiopathology
  • Male
  • Middle Aged
  • Pain / drug therapy
  • Placebos
  • Random Allocation

Substances

  • Placebos
  • Ibuprofen